Author: Giuseppe Gritti; Federico Raimondi; Diego Ripamonti; Ivano Riva; Francesco Landi; Leonardo Alborghetti; Marco Frigeni; Marianna Damiani; Caterina Micò; Stefano Fagiuoli; Roberto Cosentini; Ferdinando Luca Lorini; Fabrizio Fabretti; Jonathan Morgan; Benjamin M.J. Owens; Karan Kanhai; Jim Cowburn; Marco Rizzi; Fabiano Di Marco; Alessandro Rambaldi
Title: Use of siltuximab in patients with COVID-19 pneumonia requiring ventilatory support Document date: 2020_4_3
ID: ajurlkwr_33
Snippet: This analysis is presented to inform the medical community of the potential role of siltuximab in treating patients with SARS-CoV-2 infection who develop pneumonia/ARDS requiring CPAP/NIV. A cohort study matching patients treated with siltuximab to those treated with standard therapy at our hospital is ongoing and will report full clinical outcome upon completion. With extended follow-up, we anticipate that the natural history of the disease shal.....
Document: This analysis is presented to inform the medical community of the potential role of siltuximab in treating patients with SARS-CoV-2 infection who develop pneumonia/ARDS requiring CPAP/NIV. A cohort study matching patients treated with siltuximab to those treated with standard therapy at our hospital is ongoing and will report full clinical outcome upon completion. With extended follow-up, we anticipate that the natural history of the disease shall be better described.
Search related documents:
Co phrase search for related documents- better describe and cohort study: 1
- better describe and natural history: 1, 2
- better describe and SARS infection: 1, 2
- clinical outcome and cohort study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical outcome and extended follow: 1
- clinical outcome and medical community: 1, 2, 3, 4, 5, 6, 7
- clinical outcome and natural history: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- clinical outcome and patient treat: 1, 2
- clinical outcome and potential role: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- clinical outcome and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical outcome report and cohort study: 1
- clinical outcome report and SARS infection: 1, 2, 3, 4, 5, 6
- cohort study and medical community: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- cohort study and natural history: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cohort study and patient treat: 1
- cohort study and potential role: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cohort study and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cohort study and siltuximab potential role: 1, 2
- cohort study and siltuximab potential role medical community: 1, 2
Co phrase search for related documents, hyperlinks ordered by date